Genomic Testing Cooperative (GTC) today highlighted its Liquid Trace® cerebrospinal fluid (CSF)-based molecular profiling following new National Comprehensive Cancer Network® Guidelines for Central ...
What does the NCCN now recommend for biopsy-infeasible high-grade glioma? A new footnote added to the glioblastoma/high-grade gliomas (excluding IDH1/2-mutant gliomas ...
Amprion Launches SAAmplify®-αSYN Plus: The First & Only Commercially Available CSF Test to Detect Alpha-Synuclein Profile for Multiple System Atrophy Amprion to unveil test and new research across six ...
SAN DIEGO--(BUSINESS WIRE)--A new innovation in the detection of MSA pathology is here. Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results